Physical characterization is central to the development of small molecule pharmaceutics, but focusing on particle size can sometimes be right or wrong. Guest speaker, Dr. Mick Hurrey of SteadyMed Therapeutics, shares his experience on solid oral dosage characterization.
In this webinar, you'll learn about:
Do you have any questions or requests? Use this form to contact our specialists.